Hutchinson-Gilford progeria syndrome (HGPS) is a rare and fatal human premature ageing disease 1-5 , characterized by premature arteriosclerosis and degeneration of vascular smooth muscle cells (SMCs) [6] [7] [8] . HGPS is caused by a single point mutation in the lamin A (LMNA) gene, resulting in the generation of progerin, a truncated splicing mutant of lamin A. Accumulation of progerin leads to various ageing-associated nuclear defects including disorganization of nuclear lamina and loss of heterochromatin 9-12 . Here we report the generation of induced pluripotent stem cells (iPSCs) from fibroblasts obtained from patients with HGPS. HGPS-iPSCs show absence of progerin, and more importantly, lack the nuclear envelope and epigenetic alterations normally associated with premature ageing. Upon differentiation of HGPS-iPSCs, progerin and its ageingassociated phenotypic consequences are restored. Specifically, directed differentiation of HGPS-iPSCs to SMCs leads to the appearance of premature senescence phenotypes associated with vascular ageing. Additionally, our studies identify DNA-dependent protein kinase catalytic subunit (DNAPKcs, also known as PRKDC) as a downstream target of progerin. The absence of nuclear DNAPK holoenzyme correlates with premature as well as physiological ageing. Because progerin also accumulates during physiological ageing 6,12,13 , our results provide an in vitro iPSC-based model to study the pathogenesis of human premature and physiological vascular ageing.
Hutchinson-Gilford progeria syndrome (HGPS) is a rare and fatal human premature ageing disease [1] [2] [3] [4] [5] , characterized by premature arteriosclerosis and degeneration of vascular smooth muscle cells (SMCs) [6] [7] [8] . HGPS is caused by a single point mutation in the lamin A (LMNA) gene, resulting in the generation of progerin, a truncated splicing mutant of lamin A. Accumulation of progerin leads to various ageing-associated nuclear defects including disorganization of nuclear lamina and loss of heterochromatin [9] [10] [11] [12] . Here we report the generation of induced pluripotent stem cells (iPSCs) from fibroblasts obtained from patients with HGPS. HGPS-iPSCs show absence of progerin, and more importantly, lack the nuclear envelope and epigenetic alterations normally associated with premature ageing. Upon differentiation of HGPS-iPSCs, progerin and its ageingassociated phenotypic consequences are restored. Specifically, directed differentiation of HGPS-iPSCs to SMCs leads to the appearance of premature senescence phenotypes associated with vascular ageing. Additionally, our studies identify DNA-dependent protein kinase catalytic subunit (DNAPKcs, also known as PRKDC) as a downstream target of progerin. The absence of nuclear DNAPK holoenzyme correlates with premature as well as physiological ageing. Because progerin also accumulates during physiological ageing 6, 12, 13 , our results provide an in vitro iPSC-based model to study the pathogenesis of human premature and physiological vascular ageing.
Three HGPS primary fibroblast lines, originally isolated from patients with the classical LMNA mutation (Gly608Gly), were transduced with retroviruses encoding OCT4, SOX2, KLF4, c-MYC and green fluorescent protein (GFP). NANOG-positive colonies were effectively obtained when using early passage, but not late passage (.25), HGPS fibroblasts ( Supplementary Fig. 1a ). We focused on iPSC lines of a well characterized HGPS fibroblast line, AG01972 (refs 9-12) . Compared to normal fibroblasts, HGPS fibroblasts (AG01972) showed abnormal nuclear morphology, reduced expression of the lamina components lamin B1 and LAP2b (also known as TMPO), loss of heterochromatin markers H3K9me3, HP1a (also known as CBX5) and HDAC1, and reduced expression of nuclear proliferation marker Ki67 (also known as MKI67; Fig. 1a and Supplementary Fig. 2 ). From HGPS fibroblasts, we derived six iPSC lines. In addition, we generated control iPSC lines from wild-type fibroblasts (BJ and IMR-90 cell lines). Control and HGPS iPSC lines demonstrated pluripotent gene expression, demethylation of the OCT4 promoter and transgene silencing ( Fig. 1b and Supplementary Figs 1, 3 and 4a, and data not shown). They were maintained for more than 50 passages without a loss of pluripotency or the acquisition of detectable morphological or growth abnormalities. The pluripotency of each iPSC line was assessed by differentiation into the three embryonic germ layers in vitro, using embryoid body (EB) formation, and/or in vivo, by teratoma formation ( Supplementary Fig. 5a-d ). Out of these lines, we focused primarily on HGPS-iPSC#4 and BJ-iPSC#3 for our studies (hereafter referred to as HGPS-iPSC or BJ-iPSC). Both BJ-iPSCs and HGPS-iPSCs were able to differentiate towards specialized mesoderm-derivatives such as smooth muscle cells (SMC), endothelial cells ( Supplementary Fig. 6a ), or beating cardiomyocytes (Supplementary Movies 1 and 2). Moreover, all analysed iPSC lines showed normal chromosomal integrity (Supplementary Fig. 5e ). Finally, LMNA sequencing confirmed the presence of the classical mutation in HGPS-iPSCs ( Supplementary Fig. 5f ). Altogether, these data indicate that the somatic cells from HGPS patients, despite their significant premature senescence phenotypes and nuclear defects, have been properly reprogrammed and can be effectively maintained in a pluripotent state.
Lamin A/C protein is expressed in differentiated somatic cells but is absent in embryonic stem cells (ESCs) 11, 14 . Therefore, we next examined the expression of lamin A/C in the generated iPSC lines. As shown in Fig. 2a , lamin A/C expression is significantly downregulated in iPSCs, compared to their parental fibroblasts, whereas lamin B1 transcripts were upregulated. Although progerin should follow a similar pattern of expression as observed for lamin A/C, LMNA expression is independent of promoter methylation status ( Supplementary Fig. 4b) 15 . Indeed, a complete loss of progerin mRNA in HGPS-iPSCs was observed ( Fig. 2a ). Furthermore, expression of lamin A/C and progerin proteins was practically undetectable ( Fig. 2b and Supplementary Fig. 4c ).
Because HGPS-iPSCs did not express progerin, we examined whether the nuclear abnormalities observed in HGPS fibroblasts would also be absent at the pluripotent stage. Our results indicate that all of the epigenetic, nuclear lamina and proliferation parameters analysed in HGPS-iPSCs are indistinguishable from BJ-iPSCs (Fig. 2b, c and Supplementary Figs 3 and 7 ). In addition, the nuclei of HGPS-iPSCs displayed the characteristic wrinkles and lobes observed in hESCs and iPSCs ( Supplementary Fig. 8 ), indicative of a reprogramming of the nuclear envelope components. As the nuclear envelope associates with and regulates heterochromatin 11, 16 , we next examined genome-wide CpG methylation in HGPS fibroblasts, BJ fibroblasts, HGPS-iPSCs, BJ-iPSCs, and H9 hESCs. Using bisulphite padlock probes and Illumina sequencing, we captured and quantified the methylation level of an average of 95,932 CpG sites within a set of 16,206 well-annotated differentially methylated regions (DMRs) 17 per cell line (Supplementary Table 1 ). The correlation coefficient of the global methylation levels between the pluripotent lines (BJ-iPSCs, HGPS-iPSCs and H9 hESCs) and the corresponding fibroblasts indicated that the generated pluripotent lines are much more closely related to each other and to hESCs than the two fibroblast lines ( Fig. 2d ). Interestingly, 586 autosome genes were found to be associated with regions that showed methylation differences between HGPS and BJ fibroblasts (Supplementary Table 2 and Supplementary Fig. 9a ). Furthermore, based on DAVID 18, 19 analysis, we found that these genes were enriched for 21 Gene Ontology terms, most of which were related to development and transcriptional regulation ( Supplementary Fig.  9a ). In contrast, methylation differences between HGPS-iPSCs and BJ-iPSCs were only found for 33 autosome genes ( Supplementary  Table 3 ), which showed no significant functional enrichment. Therefore, the presence of progerin in HGPS fibroblasts seems to lead to major epigenomic changes in various pathways. These changes were no longer present in HGPS-iPSCs, coinciding with the downregulation of progerin. Finally, genome-wide mRNA profiling demonstrated that HGPS-iPSCs and BJ-iPSCs are closely related together with H9 hESCs, and different from their parental fibroblasts ( Supplementary Fig. 9b-d ). These results demonstrate the complete resetting of the nuclear architecture, epigenome and global gene expression in HGPS cells after being reprogrammed to pluripotency.
To test whether the expression of progerin could be re-activated, we first subjected HGPS-iPSCs to in vitro differentiation via EB formation. Progerin mRNA was selectively induced in differentiated HGPS-iPSCs, but not in differentiated BJ-iPSCs ( Supplementary Fig. 10a ). In contrast, lamin A was upregulated in both differentiated HGPS-iPSCs and differentiated BJ-iPSCs ( Supplementary Fig. 10a ). This reversible suppression of progerin expression by reprogramming, and subsequent reactivation upon differentiation, provides a unique model system to study human premature ageing pathologies. Progerin is known to accumulate mainly in arterial SMCs of HGPS patients, and vascular SMC degeneration is one of the characteristics of HGPS-associated arteriosclerosis 6, 7, 20 . In fact, vascular SMC senescence has been involved in the advanced arteriosclerosis of normal populations 7, 21, 22 . Therefore, we next asked whether SMCs differentiated from HGPS-iPSCs exhibit premature senescence phenotypes. Using a directed differentiation protocol, we obtained SMC populations from HGPS-iPSCs and BJ-iPSCs, the majority of which expressed characteristic SMC markers such as smooth muscle actin (SMA) and calponin ( Supplementary Fig. 6a ). Immunoblotting and PCR with reverse transcription (RT-PCR) analyses confirmed the expression of progerin in HGPS-iPSC, but not BJ-iPSC-derived SMCs (hereafter referred to as 'HGPS-SMC' and 'BJ-SMC', Supplementary Fig. 6b , c). To model SMC senescence in vitro, the differentiated SMCs were serially passaged in culture. As shown in Fig. 3a -c and Supplementary Fig. 10b , an increasing frequency of misshapen nuclei and a loss of the heterochromatin mark H3K9me3 
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were specifically observed in HGPS-SMCs after serial passaging. HGPS-SMCs at later passages (that is, passage 5) showed the typical characteristics of premature senescence, including increased senescence-associated-b-galactosidase (SA-b-Gal) staining (Fig. 3d , e and Supplementary Fig. 10c ), reduced telomere length ( Fig. 3f ), a reduced number of Ki67-positive cells ( Fig. 3g and Supplementary  Fig. 10d ), and compromised cell proliferation ( Fig. 3h and Supplementary Fig. 10e ). We also found a selective upregulation of senescencerelated transcripts in HGPS-SMCs ( Supplementary Fig. 10f ). To test whether the observed HGPS-related cell phenotypes were specific to SMCs, we differentiated HGPS-iPSCs into fibroblasts and measured progerin-associated parameters. Progerin expression in HGPS-iPSCderived fibroblasts was detectable as early as passage 5 ( Supplementary  Fig. 11a ). However, we were unable to detect a loss of lamina or heterochromatin markers before passage 10 ( Supplementary Fig.  11b , c). Nonetheless, these defects were present specifically in HGPS-iPSC-derived fibroblasts, in contrast to control iPSC-derived fibroblasts analysed at similar passage (data not shown). Thus, even though direct comparison of SMCs and fibroblasts is not possible due to their different culture conditions, our observations demonstrate that mesoderm lineages derived from HGPS-iPSCs display a characteristic HGPS phenotype. We next investigated whether progerin accumulation is the direct cause of the accelerated cell senescence observed in HGPS-SMCs. To this end, we induced ectopic expression of progerin in human primary vascular SMCs. We found that introduction of progerin in wild-type SMCs resulted in compromised cell proliferation and nuclear defects, as we had observed in HGPS-SMCs ( Fig. 3i and Supplementary Fig. 12 ). As a complementary approach, we transduced HGPS-iPSCs with a lentiviral vector expressing a progerin-specific short hairpin RNA (shRNA) 23 . The modified iPSCs showed normal karyotypes as well as normal expression of lamina/epigenetic and pluripotent markers ( Supplementary Fig. 13a, b) . After EB-based differentiation, both the mRNA and protein levels of progerin, but not those of lamin A, were substantially downregulated in the progerin-shRNA 'corrected' HGPS-iPSCs compared to control cells ( Fig. 3j and Supplementary Fig. 13c, d ). We next differentiated these 'progerin-free' HGPS-iPSCs into SMCs ( Supplementary Fig. 14a ). A marked improvement in the proliferation capability, as well as a downregulation of senescence-related transcripts, was found in the SMCs differentiated from the corrected HGPS-iPSCs ( Fig. 3k and Supplementary Fig. 14b, c) . Furthermore, transduction of progerin shRNA into early passage HGPS-iPSCderived fibroblasts resulted in a clear restoration of nuclear morphology and heterochromatin markers after extended culture ( Supplementary  Fig. 15 ). Taken together, these data identify progerin as the key factor underlying the premature senescence phenotypes of HGPS-iPSCderived cells.
Because phenotypic characteristics of premature ageing were able to be recapitulated by directed differentiation of the HGPS-iPSCs, we next investigated whether this model could serve to identify novel senescence-related markers. By using a sensitive MudPIT proteomic approach 24,25 , we identified DNA-dependent protein kinase catalytic subunit (DNAPKcs) as a hitherto unknown binding partner of progerin ( Supplementary Table 4 ). DNAPK holoenzyme, comprising DNAPKcs and its regulatory subunits Ku70/Ku80 (also known as XRCC6 and XRCC5, respectively), is involved in various ageing-related cellular events 26, 27 , and DNAPKcs or Ku70/Ku80-deficient mice exhibit accelerated ageing 27, 28 . To further confirm the association of progerin with DNAPKcs, we performed co-immunoprecipitation experiments. As shown in Fig. 4a , ectopically expressed progerin associated tightly with endogenous DNAPKcs. In contrast, lamin A showed weak interaction with DNAPKcs, whereas both progerin and lamin A exhibited similar binding to lamin B1. Neither progerin nor lamin A co-immunoprecipitated with endogenous WRN protein. Since most of 
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the nuclear proteins in complex with lamin A are destabilized in HGPS cells 9, 29 , we analysed the status of DNAPKcs in primary HGPS fibroblasts. We observed decreased nuclear DNAPKcs in HGPS fibroblasts when compared to normal fibroblasts (Fig. 4b, c ). In addition, the regulatory subunits Ku70/Ku80 were also downregulated in HGPS fibroblasts ( Supplementary Fig. 16a ). Interestingly, we detected a complete restoration of DNAPKcs/Ku70/Ku80 expression in HGPS-iPSCs (Fig. 4b, d and Supplementary Figs 3 and 16b ), although a deficiency in the expression of these proteins reappeared after differentiation into SMCs (Fig. 4e) . These observations indicate that the downregulation of DNAPKcs in HGPS cells is dependent on the accumulation of progerin in differentiated cells. In fact, ectopic expression of progerin in primary vascular SMCs diminished DNAPKcs/Ku80 protein expression ( Fig. 4f and Supplementary Fig. 17 ). We next tested whether inactivation of DNAPKcs could partially contribute to some of the phenotypes observed in HGPS-SMCs. We found that knockdown of DNAPKcs reduced the proliferation of primary vascular SMCs ( Supplementary  Fig. 18a ). Finally, we extended our results and found that progressive loss of DNAPKcs/Ku70/Ku80 also occurs in fibroblasts isolated from normally ageing individuals ( Supplementary Fig. 18b ). Overall, our data indicate that deficiency of the DNAPK holoenzyme may constitute a novel marker for premature as well as physiological ageing. In summary, our results not only highlight the plasticity of the lamina-epigenetics axis, but also point to the fact that the altered structure of the nuclear envelope, as well as the epigenetic modifications that accumulate during physiological ageing 12 or under specific disease conditions 1, 11 , can be restored to normalcy by reprogramming (Supplementary Fig. 19 ). The gradual onset and complexity of ageing has impeded progress in understanding the pathogenesis of ageing-related cardiovascular disorders. Recently, striking similarities between normal ageing-associated and HGPS-associated arteriosclerosis have been reported 6, 16 . Indeed, the levels of progerin increase gradually during physiological ageing 6 . Our study provides the first evidence that, in a progerin-dependent manner, HGPS-iPSC-derived SMCs reach senescence-related phenotypes earlier than their normal counterparts. The iPSC-based accelerated ageing model presented here and in ref. 30 may provide an avenue to model and study the pathogenesis of human ageing-related vascular diseases as well as various human laminopathies 1 .
METHODS SUMMARY
iPSCs were generated from human fibroblasts with retroviruses encoding OCT4/ SOX2/KLF4/c-MYC/GFP, and grown on MEF feeder cells or Matrigel. SMCs were differentiated from iPSCs-derived CD34 1 progenitor cells following an OP9based protocol. 
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cycles. PCR products were purified using 2% Size-Select E-gel (Invitrogen) and reamplified for 10 cycles using Phusion HF enzyme (NEB). PCR products were cloned using Zero-blunt PCR Cloning kit (Invitrogen) and heat transfected to TOP10 Escherichia coli competent cells (Invitrogen). Individual colonies were selected and sent for single pass sequencing. DNA microarray and bioinformatics analysis. The GeneChip microarray processing was performed by the Functional Genomica Core in the Institute for Research in Biomedicine (Barcelona, Spain) according to the manufacturer's protocols (Affymetrix). The amplification and labelling were processed as indicated in Nugen protocol with 25 ng starting RNA. For each sample, 3.75 mg ssDNA were labelled and hybridized to the Affymetrix HG-U133 Plus 2.0 chips. Expression signals were scanned on an Affymetrix GeneChip Scanner (7G upgrade). The data extraction was done by the Affymetrix GCOS software v.1.4.
The statistical analysis of the data was performed using ArrayStar 3. Briefly, raw CEL files were imported together with gene annotation from NetAffix (from 11/ 13/2009) and after checking for top replication quality for each of the five pairs of samples (R 2 . 0.99), data was summarized at the gene level (20,765 genes) and the median was used for each gene and sample type. As both H9 hESCs and HGPS-iPSCs originate from female samples, and in order to remove any possible bias introduced by the X and Y chromosome-coded genes, we performed the same analysis with only autosome genes (19,884 genes) . The result of the hierarchical clustering is very similar to the one using all genes and is shown in Supplementary  Fig. 9b . In addition, a principal component analysis was performed on RMAnormalized probeset intensity values for autosomes using the prcomp function in R (http://www.r-project.org/) (the same figure including all genes gave highly similar results, data not shown). A figure illustrating the two first principal components is shown in Supplementary Fig. 9c . Differences between some of the samples is shown using scatter plot of RMA-normalized intensity values in Supplementary Fig. 9d . Multidimensional protein identification technology (MudPIT) analysis of progerin-associated proteins. The immunoprecipitation for MudPIT assay was performed as previously described 24, 25 . In brief, HEK293T cells were transfected with GFP-progerin or GFP and maintained in culture for 48 h. After cells were lysed, the GFP-progerin, GFP, and their associated proteins were immunoadsorbed to anti-GFP agarose. The immunoprecipitates were then eluted with 8 M urea in 100 mM Tris, pH 8.5. The samples were reduced by adding 0.3 ml of 1 M TCEP (for a final concentration of 5 mM TCEP) and incubated at room temperature. To alkylate, 1.2 ml of iodoacetamide (10 mM final concentration) was added and the samples were subsequently incubated at room temperature in the dark for 15 min. The addition of 180 ml of 100 mM Tris pH 8.5 diluted the solutions to 2 M urea. Calcium chloride (100 mM) was then added (2.4 ml) for a final concentration of 1 mM CaCl 2 . Trypsin (0.5 mg ml 21 ) was added in the amount of 7.0 ml. The resulting mixtures were then shaken for 18 h and incubated in the dark at 37 uC. To neutralize 13.5 ml of formic acid (90%) was added for a final concentration of 5% formic acid. The tubes were centrifuged for 30 min at 2 uC in a table-top centrifuge. Upon completion of the digestion, the proteins were pressure-loaded onto a fused silica capillary desalting column containing 3 cm of 5-mm strong cation exchange (SCX) followed by 3 cm of 5-mm C18 (reverse phase or RP material) packed into an undeactivated 250-mm i.d capillary. Using 1.5 ml of buffer A (95% water, 5% acetonitrile and 0.1% formic acid) the desalting columns were washed overnight. Following the desalting process, a 100-mm internal diameter capillary consisting of a 10-mm laser pulled tip packed with 10 cm 3-mm Aqua C18 material (Phenomenex) was attached to the filter union (desalting column-filter union-analytical column) and the entire split-column (desalting column-filter union-analytical column) was placed in line with an Agilent 1100 quaternary HPLC (Palo Alto, CA) and analysed using a modified 6-step separation, described previously 25 . The buffer solutions used were 5% acetonitrile/0.1% formic acid (buffer A), 80% acetonitrile/0.1% formic acid (buffer B), and 500 mM ammonium acetate/5% acetonitrile/0.1% formic acid (buffer C).
Step 1 consisted of a 90 min gradient from 0-100% buffer B. Steps 2-5 had the following profile: 3 min of 100% buffer A, 2 min of X% buffer C, a 10 min gradient from 0-15% buffer B, and a 97 min gradient from 15-45% buffer B. The 2 min buffer C percentages (X) were 20, 40, 60, 80% respectively for the 6-step analysis. In the final step, the gradient contained: 3 min of 100% buffer A, 20 min of 100% buffer C, a 10 min gradient from 0-15% buffer B, and a 107 min gradient from 15-70% buffer B. As peptides eluted from the microcapillary column, they were electrosprayed directly into an LTQ 2-dimensional ion trap mass spectrometer (ThermoFinnigan) with the application of a distal 2.4 kV spray voltage. A cycle of one full-scan mass spectrum (400-1,400 m/z) followed by 8 data-dependent MS/MS spectra at a 35% normalized collision energy was repeated continuously throughout each step of the multidimensional separation. Application of mass spectrometer scan functions and HPLC solvent gradients were controlled by the Xcalibur data system.
As each step was executed, its spectra were recorded to a RAW file. This data was then converted into .ms2 format through the use of RawXtract (Version 1.9). From the .ms2 files, poor quality spectra were removed from the data set using an automated spectral quality assessment algorithm 37 . MS/MS spectra remaining after filtering were searched with the SEQUEST algorithm 38 against the NCBI RefSeq Human (04-23-2010) protein database concatenated to a decoy database in which the sequence for each entry in the original database was reversed 25, 39 . All searches were parallelized and performed on a Beowulf computer cluster consisting of 100 1.2 GHz Athlon CPUs 40 . No enzyme specificity was considered for any search. SEQUEST results were assembled and filtered using the DTASelect (version 2.0) program. DTASelect 2.0 uses a linear discriminant analysis to dynamically set XCorr and DeltaCN thresholds for the entire data set to achieve a user-specified false positive rate. The false positive rates are estimated by the program from the number and quality of spectral matches to the decoy database. The hits detected uniquely in the GFP-progerin sample but not in GFP sample represent proteins that are specifically associated with progerin, by either direct or indirect interactions. Co-immunoprecipitation. BJ human fibroblasts were transduced with retrovirus encoding GFP-progerin, GFP-lamin A or GFP, and maintained in culture for 72 h. For immunoprecipitation, cells were lysed in ice-cold lysis buffer (250 mM NaCl, 0.5% Triton X-100, 50 mM Tris, pH 7.5, 1 mM EGTA, 1 mM EDTA, 10% glycerol, and complete protease inhibitor cocktail (Roche Diagnostics)). Samples were briefly sonicated and immunoprecipitated by incubating with anti-GFP agarose. The immunoprecipitates were washed extensively in lysis buffer, eluted in SDS sample buffer, and subjected to immunoblotting. Senescence-associated beta-galactosidase (SA-bgal) assay. SA-bgal assay were performed based on previously described methods 41 . Measurement of telomere length. Genomic DNA was isolated from 1 3 10 6 cells. The telomere-specific oligonucleotide probe (59-TTAGGGTTAGGGTTAGGG TTAGGG-39; ValueGene) was end-labelled using c-32 P-ATP (MP Biomedicals) and T4 polynucleotide kinase (NEB). Two mg of genomic DNA for each sample was digested with AluI (NEB) and MboI (NEB) and subjected to Southern analysis with the telomere-specific probe. Mean telomere length was calculated from P OD i /( P OD i / P MW i ). OD i and MW i are optical density and molecular weight at a given position i, respectively. Cell proliferation assay. Cell proliferation was determined with CellTiter 96 AQ ueous One Solution Cell Proliferation Assay (MTS (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium)), according to the protocol provided by the manufacturer (Promega). Statistical analysis. Results are presented as mean 6 s.d. Comparisons were performed with student's t-test or one-way anova. P , 0.05 was defined as statistically significant.
